Structure Therapeutics Inc. (GPCR) /
The profitability of Structure Therapeutics Inc. over the past 4 years
Chart Structure Therapeutics Inc.: operating income, net income, fiscal 2022–2025 Open the chart →Structure Therapeutics Inc. reported a net loss of $141.2M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $176.56M. It reported a loss in all 4 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$176.56M | -$141.2M |
| 2024ended Dec 31, 2024 | -$158.23M | -$122.53M |
| 2023ended Dec 31, 2023 | -$102.78M | -$89.62M |
| 2022ended Dec 31, 2022 | -$52.56M | -$51.32M |
Fiscal years as Structure Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Structure Therapeutics Inc.
- The cash flow of Structure Therapeutics Inc.
- The debt of Structure Therapeutics Inc.
- All of Structure Therapeutics Inc.'s financials, charted
Companies of a similar size
- BCOBRINK’S CO
- STWDStarwood Property Trust, Inc.
- JOBYJoby Aviation, Inc.
- SIGSIGNET JEWELERS LIMITED
- OKLOOklo Inc.
Not investment advice. This page shows what Structure Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.